Showing 1221-1230 of 7167 results for "".
High-Dose Ipilimumab Shows Benefits in Advanced Melanoma: Implications for Care
https://practicaldermatology.com/topics/skin-cancer-photoprotection/high-dose-ipilimumab-shows-benefits-in-advanced-melanoma-implications-for-care/20687/Although treatment is associated with a high rate of toxicity, survival benefit is extended at a higher dose.Advancements in Skin Protection and Skin Cancer Management
https://practicaldermatology.com/topics/skin-cancer-photoprotection/advancements-in-skin-protection-and-skin-cancer-management/20720/Experts discuss some of the latest developments with an emphasis on implications for patient care.The Invasion of the Picoseconds
https://practicaldermatology.com/topics/practice-management/the-invasion-of-the-picoseconds/20763/Pico devices are finding their niche, with expanded applications that may make them more attractive for practices.Invasive Melanoma: Incidence, Mortality Continue to Climb
https://practicaldermatology.com/topics/practice-management/invasive-melanoma-incidence-mortality-continue-to-climb/20780/The burden of disease is growing, despite best efforts to combat melanoma.Now What?
https://practicaldermatology.com/topics/psoriasis/now-what/20840/A look at what's now, what's next, and how dermatology practice continues to evolve with drugs, technologies, and opportunities.Staying Ahead of the Curve
https://practicaldermatology.com/topics/practice-management/staying-ahead-of-the-curve/20882/Is your practice website responsive enough?5 Ideas to Strengthen Your Dermatology Mobile Marketing
https://practicaldermatology.com/topics/practice-management/5-ideas-to-strengthen-your-dermatology-mobile-marketing/20873/Mobile search has made dramatic strides in recent years. It is time to boost your dermatology online exposure through mobile marketing.Open Access: Thoughts for the Ballot Box
https://practicaldermatology.com/topics/practice-management/open-access-thoughts-for-the-ballot-box/20908/Access to drugs, derms at stake in US presidential election.Biosimilars: What's Coming for Labeling?
https://practicaldermatology.com/topics/practice-management/biosimilars-whats-coming-for-labeling/20934/The public comment period on draft labeling guidance will end next month.Doctors Betrayed by Traditional Financial Strategies
https://practicaldermatology.com/topics/practice-management/doctors-betrayed-by-traditional-financial-strategies/20960/Part one of this two-part series explores why financial advice for the “average” consumer isn't always the best advice for dermatologists.